Skip to main content
logo
Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,820.00
+195.00 (7.43%)
At close: Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Pharmaceutical
100.00M
Log In
Log In
Log In
Log In
Technology Transfer
-
Log In
Log In
Log In
Log In
Technology Transfer Growth
-
Log In
Log In
Log In
Log In
Transfer to Test Substance
-
Log In
Log In
Log In
Log In
Transfer to Test Substance Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
South Korea
100.00M
Log In
Log In
Log In
Log In
South Korea Growth
-96.69%
Log In
Log In
Log In
Log In
Europe
-
Log In
Log In
Log In
Log In
Europe Growth
-
Log In
Log In
Log In
Log In